OBI-3424
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for OBI-3424, covering 2024-10-15 to 2025-08-15. Get the full timeline:
Most recent: Clinical Trial Update: Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL) [Phase 1, Phase 2]